UNC Health Medication Formulary
QR Code Add Formweb to your mobile device
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary
Search results for:

eculizumab

eculizumab
Drug Name Form Strength ARHS Blue Ridge Caldwell Chatham Johnston Lenoir Medical Center Nash Pardee Rex Rockingham Southeastern Wayne Youth Behavioral Health
Eculizumab SOLUTION, INTRAVENOUS 10 mg/mL (30 mL)                
Eculizumab-aagh SOLUTION, INTRAVENOUS 10 mg/mL (30 mL)                          

UNC Health

System Formulary Restriction:

Inpatient:

    • Eculizumab-aagh (Epysqli) may be used inpatient if criteria is met based on the UNC Medical Center Formulary Restrictions below.

Outpatient:

    • Eculizumab-aagh (Epysqli) is the recommended first line product.
    • Eculizumab (Solaris: Restricted to patients in outpatient or clinic encounters (ie, no inpatient use)

UNC Health IV Compendium Guideline

Med Center
     UNC Medical Center Formulary Restrictions

     Eculizumab (Soliris) Dispensing Form

Rex
     Rex Hematology-Oncology Formulary Restrictions


Last updated: Jan. 14, 2026







This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.